Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) universal screening in gravids during labor and delivery
Savirón-Cornudella, Ricardo (Universidad de Zaragoza) ; Villalba, Ana ; Zapardiel, Javier ; Andeyro-Garcia, Mercedes ; Esteban Escaño, Luis Mariano ; Pérez López, Faustino Ramón
Resumen: Objective
To screen pregnant women at risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during delivery using reverse-transcription polymerase chain reaction (RT-PCR) test and serum immunoglobulin (Ig) testing.
Method
Between March 31 st and August 31 st of 2020, consecutive pregnant women admitted for labor and delivery in a single hospital were screened for SARS-CoV-2 with nasopharyngeal RT-PCR swab tests and detection of serum IgG and IgM.
Results
We studied 266 pregnant women admitted for labor and delivery. The prevalence of acute or past SARS-CoV-2 infection was 9.0 %, including (i) two cases with respiratory symptoms of SARS-Co-V-2 infection and positive RT-PCR; (ii) four asymptomatic women with positive RT-PCR without clinical symptoms and negative serological tests between two and 15 weeks later; and (iii) two women with false positive RT-PCR due to technical problems. All newborns of the 6 pregnant women with RT-PCR positive had negative RT-PCR and did not require Neonatal Intensive Care Unit admission. There were eighteen asymptomatic women with positive serological IgG tests and negative RT-PCR.
Conclusion
In our cohort of gravids, we found 2.2 % of women with positive RT-PRC tests and 6.7 % with positive serological tests during the first wave of the SARS-CoV-2 pandemic.
Idioma: Inglés
DOI: 10.1016/j.ejogrb.2020.11.069
Año: 2021
Publicado en: European Journal of Obstetrics and Gynecology and Reproductive Biology 256 (2021), 400-404
ISSN: 0301-2115
Factor impacto JCR: 2.831 (2021)
Categ. JCR: REPRODUCTIVE BIOLOGY rank: 21 / 31 = 0.677 (2021) - Q3 - T3
Categ. JCR: OBSTETRICS & GYNECOLOGY rank: 46 / 85 = 0.541 (2021) - Q3 - T2
Factor impacto CITESCORE: 3.3 - Medicine (Q2)
Factor impacto SCIMAGO: 0.635 - Reproductive Medicine (Q2) - Obstetrics and Gynecology (Q2)
Tipo y forma: Artículo (PostPrint)
Área (Departamento): Area Anatom.Embriol.Humana (Dpto. Anatom.Histolog.Humanas)
Debe reconocer adecuadamente la autoría, proporcionar un enlace a la licencia e indicar si se han realizado cambios. Puede hacerlo de cualquier manera razonable, pero no de una manera que sugiera que tiene el apoyo del licenciador o lo recibe por el uso que hace. No puede utilizar el material para una finalidad comercial. Si remezcla, transforma o crea a partir del material, no puede difundir el material modificado.
Exportado de SIDERAL (2023-05-18-13:14:55)
Visitas y descargas
To screen pregnant women at risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during delivery using reverse-transcription polymerase chain reaction (RT-PCR) test and serum immunoglobulin (Ig) testing.
Method
Between March 31 st and August 31 st of 2020, consecutive pregnant women admitted for labor and delivery in a single hospital were screened for SARS-CoV-2 with nasopharyngeal RT-PCR swab tests and detection of serum IgG and IgM.
Results
We studied 266 pregnant women admitted for labor and delivery. The prevalence of acute or past SARS-CoV-2 infection was 9.0 %, including (i) two cases with respiratory symptoms of SARS-Co-V-2 infection and positive RT-PCR; (ii) four asymptomatic women with positive RT-PCR without clinical symptoms and negative serological tests between two and 15 weeks later; and (iii) two women with false positive RT-PCR due to technical problems. All newborns of the 6 pregnant women with RT-PCR positive had negative RT-PCR and did not require Neonatal Intensive Care Unit admission. There were eighteen asymptomatic women with positive serological IgG tests and negative RT-PCR.
Conclusion
In our cohort of gravids, we found 2.2 % of women with positive RT-PRC tests and 6.7 % with positive serological tests during the first wave of the SARS-CoV-2 pandemic.
Idioma: Inglés
DOI: 10.1016/j.ejogrb.2020.11.069
Año: 2021
Publicado en: European Journal of Obstetrics and Gynecology and Reproductive Biology 256 (2021), 400-404
ISSN: 0301-2115
Factor impacto JCR: 2.831 (2021)
Categ. JCR: REPRODUCTIVE BIOLOGY rank: 21 / 31 = 0.677 (2021) - Q3 - T3
Categ. JCR: OBSTETRICS & GYNECOLOGY rank: 46 / 85 = 0.541 (2021) - Q3 - T2
Factor impacto CITESCORE: 3.3 - Medicine (Q2)
Factor impacto SCIMAGO: 0.635 - Reproductive Medicine (Q2) - Obstetrics and Gynecology (Q2)
Tipo y forma: Artículo (PostPrint)
Área (Departamento): Area Anatom.Embriol.Humana (Dpto. Anatom.Histolog.Humanas)
Debe reconocer adecuadamente la autoría, proporcionar un enlace a la licencia e indicar si se han realizado cambios. Puede hacerlo de cualquier manera razonable, pero no de una manera que sugiera que tiene el apoyo del licenciador o lo recibe por el uso que hace. No puede utilizar el material para una finalidad comercial. Si remezcla, transforma o crea a partir del material, no puede difundir el material modificado.Exportado de SIDERAL (2023-05-18-13:14:55)
Enlace permanente:
Visitas y descargas
Este artículo se encuentra en las siguientes colecciones:
Artículos
Registro creado el 2021-12-01, última modificación el 2023-05-19